Sanofi headquarters raided in broader French tax fraud investigationnews2025-11-26T11:46:20+00:00November 26th, 2025|Endpoints News|
Kallyope scraps one of two mid-stage migraine drugsnews2025-11-26T10:37:29+00:00November 26th, 2025|Endpoints News|
Otsuka’s anti-APRIL antibody gets FDA approval for kidney disease IgANnews2025-11-26T00:52:17+00:00November 26th, 2025|Endpoints News|
CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second roundnews2025-11-25T23:09:56+00:00November 25th, 2025|Endpoints News|
What a team of ex-Amazon employees are building next in healthcarenews2025-11-25T17:48:16+00:00November 25th, 2025|Endpoints News|
Pharma faces deadline to bring IRA fight to Supreme Court as first set of negotiated prices loomsnews2025-11-25T17:32:39+00:00November 25th, 2025|Endpoints News|
FDA OKs Sarepta study of new immune suppression approach with Elevidys; Gilead buys preclinical TREX1 programnews2025-11-25T15:50:45+00:00November 25th, 2025|Endpoints News|
Novo Nordisk’s amycretin cuts body weight, blood sugar in Phase 2 diabetes trialnews2025-11-25T14:31:02+00:00November 25th, 2025|Endpoints News|
Novartis plans to lay off 550 workers at Swiss factory news2025-11-25T14:18:48+00:00November 25th, 2025|Endpoints News|
FDA approves Novartis’ Itvisma for older patients with spinal muscular atrophynews2025-11-25T12:09:26+00:00November 25th, 2025|Endpoints News|
